-transparent.png){kind=logo}
Calcium channel-blocking agent verapamil has been established to be an effective drug to modulate the action of many anticancer drugs. In this study, we examined the effect of verapamil on the cytotoxicity of mitoxantrone in human chronic myeloid leukemia (CML) cells. Mitoxantrone alone exhibited dose-dependent inhibition of DNA biosynthesis in CML cells. The addition of verapamil (3.3 microM) enhanced the responsiveness of CML cells to mitoxantrone (1 microgram/ml) cytotoxicity indicated by significant increased inhibition of thymidine incorporation (p less than 0.001). The present study demonstrates the possible efficacy of verapamil in the chemotherapy of CML with mitoxantrone.
K Satyamoorthy, and
M P Chitnis, and
S G Pradhan, and
S H Advani
January 1987,
Neoplasma,
K Satyamoorthy, and
M P Chitnis, and
S G Pradhan, and
S H Advani
June 1989,
The Indian journal of medical research,
K Satyamoorthy, and
M P Chitnis, and
S G Pradhan, and
S H Advani
January 1991,
Neoplasma,
K Satyamoorthy, and
M P Chitnis, and
S G Pradhan, and
S H Advani
January 1984,
Oncology,
K Satyamoorthy, and
M P Chitnis, and
S G Pradhan, and
S H Advani
January 1986,
Neoplasma,
K Satyamoorthy, and
M P Chitnis, and
S G Pradhan, and
S H Advani
February 2012,
Journal of molecular medicine (Berlin, Germany),
K Satyamoorthy, and
M P Chitnis, and
S G Pradhan, and
S H Advani
January 1990,
Neoplasma,
K Satyamoorthy, and
M P Chitnis, and
S G Pradhan, and
S H Advani
January 1991,
Neoplasma,
K Satyamoorthy, and
M P Chitnis, and
S G Pradhan, and
S H Advani
January 1993,
Cancer investigation,
K Satyamoorthy, and
M P Chitnis, and
S G Pradhan, and
S H Advani
April 2014,
Oncology letters,
